We previously demonstrated that TLR9 has an important role in TNBC (9) and showed that, while low tumor TLR9 expression was associated with significantly shortened breast cancer-specific survival in patients with TNBC, TLR9 had no prognostic value in breast cancer patients with ER+ tumors (9). Here, TLR9 is linked to breast carcinoma.